Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

Technology appraisal guidance
Reference number: TA210
Published: 15 December 2010

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix A provisional matrix of stakeholders

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix A provisional matrix of stakeholders

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix A provisional matrix of stakeholders
29 July 2013
(102.64 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 July 2013